Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17785315 | 1.00 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785266 | 0.95 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785330 | 0.91 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785325 | 0.88 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785364 | 0.88 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785440 | 0.87 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785356 | 0.87 | KLKB1 (0.87) | KLKB1 | |
| SCHEMBL17785439 | 0.87 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785274 | 0.86 | KLKB1 (1.00) | KLKB1 | |
| SCHEMBL17785310 | 0.85 | KLKB1 (1.00) | KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074903-A1 | N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | DRI UK LP (KY) | 2025-03-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074903-A1 | N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | KLKB1, BDKRB1, BDKRB2 | KLKB1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.